City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference (RNAi) therapies headed by a ...
Although real progress has been made in managing depression over recent decades, significant hurdles remain. In fact, around ...
The EMA's human medicines committee, the CHMP, has recommended approval of Eli Lilly's oral GLP-1 agonist Foundayo for weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results